MycRX nominated MRX-5287 as a development candidate
The CEO discussed the company's novel approach to targeting MYC-driven cancers on Syneos Health's podcast.
Latest MycRx News & Updates
See the latest news and media coverage for MycRx. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of Myc oncoprotein inhibitors
mycrxpharma.com- Headquarters
- Austin, United States
- Founded year
- 2013
- Company type
- Private company
- Number of employees
- 2–15
- Industry
- Pharmaceuticals
Last updated
Latest news about MycRx
Company announcements
MycRX CEO joining Tempus to discuss real-world data
Dr. Nick Glover will share how RWD informs strategy for their Myc inhibitor program.
Media coverage
MycRX - 2025 Company Profile, Funding & Competitors - Tracxn
MycRX - Developer of small molecule inhibitors for the treatment of cancer. Raised funding from 2 investors.
Never miss news about MycRx
Track MycRx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Recursion
Hey API
ScottsMiracle-Gro
New Era Energy & Digital
Southland
Citizens, Inc.
ACM Research
SOBRsafe
TerraFirma
Willow
Revel
Vorflux
Ode
SoFi
Aehr
TRX Gold
Lexroom
Hertz
Agenus
Kratos
Pophouse
Altimmune
Helus
Forgent
Lakewood Amedex
Presidio
Dropbox
TikTok
Shoals
FF
Deployable Energy
Champion Homes
American Airlines
Hyster-Yale
Nanya
PrismML